Global S-Amlodipine Market Insights, Forecast to 2034
S AMLODIPINE belongs to a class of medicines called calcium channel blockers which are primarily taken to treat hypertension (high blood pressure) and angina (chest pain).
Global S-Amlodipine market is expected to reach to US$ 39620 million in 2023, with a positive growth of %, compared with US$ 35600 million in 2024 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, S-Amlodipine industry is evaluated to reach US$ 75320 million in 2034. The CAGR will be 11.3% during 2023 to 2034.
Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.
Report Covers
This report presents an overview of global S-Amlodipine market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global S-Amlodipine market with multiple angles. Items like regional sales, revenue from 2018 to 2034 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Aristo Pharmaceuticals Pvt Ltd
Novartis
Pfizer
Lek
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Sanis Health
Jamp Pharma
Accel Pharma
Jubilant Generics
Angita Pharma
Florida DOH Central Pharmacy
Chengdu Di'ao Pharmaceutical Group Co., Ltd.
Yangzijiang Pharmaceutical
Segment by Type
Amlodipine Besylate Tablets
Amlodipine Mesylate Tablets
Amlodipine Maleate Tablets
Segment by Application
Hypertension
Angina pectoris
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2034
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ S-Amlodipine plant distribution, commercial date of S-Amlodipine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2034 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2034 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2034 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2034 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2034 in China. Product sales and revenue analysis of China from 2018 to 2034
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, S-Amlodipine introduction, etc. S-Amlodipine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of S-Amlodipine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Table of Content
1 Study Coverage
1.1 S-Amlodipine Product Introduction
1.2 Market by Type
1.2.1 Global S-Amlodipine Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Amlodipine Besylate Tablets
1.2.3 Amlodipine Mesylate Tablets
1.2.4 Amlodipine Maleate Tablets
1.3 Market by Application
1.3.1 Global S-Amlodipine Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hypertension
1.3.3 Angina pectoris
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global S-Amlodipine Sales Estimates and Forecasts 2018-2034
2.2 Global S-Amlodipine Revenue by Region
2.2.1 Global S-Amlodipine Revenue by Region: 2018 VS 2024 VS 2034
2.2.2 Global S-Amlodipine Revenue by Region (2018-2023)
2.2.3 Global S-Amlodipine Revenue by Region (2024-2034)
2.2.4 Global S-Amlodipine Revenue Market Share by Region (2018-2034)
2.3 Global S-Amlodipine Sales Estimates and Forecasts 2018-2034
2.4 Global S-Amlodipine Sales by Region
2.4.1 Global S-Amlodipine Sales by Region: 2018 VS 2024 VS 2034
2.4.2 Global S-Amlodipine Sales by Region (2018-2023)
2.4.3 Global S-Amlodipine Sales by Region (2024-2034)
2.4.4 Global S-Amlodipine Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global S-Amlodipine Sales by Manufacturers
3.1.1 Global S-Amlodipine Sales by Manufacturers (2018-2023)
3.1.2 Global S-Amlodipine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of S-Amlodipine in 2024
3.2 Global S-Amlodipine Revenue by Manufacturers
3.2.1 Global S-Amlodipine Revenue by Manufacturers (2018-2023)
3.2.2 Global S-Amlodipine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by S-Amlodipine Revenue in 2024
3.3 Global Key Players of S-Amlodipine, Industry Ranking, 2021 VS 2024 VS 2023
3.4 Global S-Amlodipine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global S-Amlodipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of S-Amlodipine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of S-Amlodipine, Product Offered and Application
3.8 Global Key Manufacturers of S-Amlodipine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global S-Amlodipine Sales by Type
4.1.1 Global S-Amlodipine Historical Sales by Type (2018-2023)
4.1.2 Global S-Amlodipine Forecasted Sales by Type (2024-2034)
4.1.3 Global S-Amlodipine Sales Market Share by Type (2018-2034)
4.2 Global S-Amlodipine Revenue by Type
4.2.1 Global S-Amlodipine Historical Revenue by Type (2018-2023)
4.2.2 Global S-Amlodipine Forecasted Revenue by Type (2024-2034)
4.2.3 Global S-Amlodipine Revenue Market Share by Type (2018-2034)
4.3 Global S-Amlodipine Price by Type
4.3.1 Global S-Amlodipine Price by Type (2018-2023)
4.3.2 Global S-Amlodipine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global S-Amlodipine Sales by Application
5.1.1 Global S-Amlodipine Historical Sales by Application (2018-2023)
5.1.2 Global S-Amlodipine Forecasted Sales by Application (2024-2034)
5.1.3 Global S-Amlodipine Sales Market Share by Application (2018-2034)
5.2 Global S-Amlodipine Revenue by Application
5.2.1 Global S-Amlodipine Historical Revenue by Application (2018-2023)
5.2.2 Global S-Amlodipine Forecasted Revenue by Application (2024-2034)
5.2.3 Global S-Amlodipine Revenue Market Share by Application (2018-2034)
5.3 Global S-Amlodipine Price by Application
5.3.1 Global S-Amlodipine Price by Application (2018-2023)
5.3.2 Global S-Amlodipine Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada S-Amlodipine Market Size by Type
6.1.1 US & Canada S-Amlodipine Sales by Type (2018-2034)
6.1.2 US & Canada S-Amlodipine Revenue by Type (2018-2034)
6.2 US & Canada S-Amlodipine Market Size by Application
6.2.1 US & Canada S-Amlodipine Sales by Application (2018-2034)
6.2.2 US & Canada S-Amlodipine Revenue by Application (2018-2034)
6.3 US & Canada S-Amlodipine Market Size by Country
6.3.1 US & Canada S-Amlodipine Revenue by Country: 2018 VS 2024 VS 2034
6.3.2 US & Canada S-Amlodipine Sales by Country (2018-2034)
6.3.3 US & Canada S-Amlodipine Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe S-Amlodipine Market Size by Type
7.1.1 Europe S-Amlodipine Sales by Type (2018-2034)
7.1.2 Europe S-Amlodipine Revenue by Type (2018-2034)
7.2 Europe S-Amlodipine Market Size by Application
7.2.1 Europe S-Amlodipine Sales by Application (2018-2034)
7.2.2 Europe S-Amlodipine Revenue by Application (2018-2034)
7.3 Europe S-Amlodipine Market Size by Country
7.3.1 Europe S-Amlodipine Revenue by Country: 2018 VS 2024 VS 2034
7.3.2 Europe S-Amlodipine Sales by Country (2018-2034)
7.3.3 Europe S-Amlodipine Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China S-Amlodipine Market Size
8.1.1 China S-Amlodipine Sales (2018-2034)
8.1.2 China S-Amlodipine Revenue (2018-2034)
8.2 China S-Amlodipine Market Size by Application
8.2.1 China S-Amlodipine Sales by Application (2018-2034)
8.2.2 China S-Amlodipine Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia S-Amlodipine Market Size by Type
9.1.1 Asia S-Amlodipine Sales by Type (2018-2034)
9.1.2 Asia S-Amlodipine Revenue by Type (2018-2034)
9.2 Asia S-Amlodipine Market Size by Application
9.2.1 Asia S-Amlodipine Sales by Application (2018-2034)
9.2.2 Asia S-Amlodipine Revenue by Application (2018-2034)
9.3 Asia S-Amlodipine Sales by Region
9.3.1 Asia S-Amlodipine Revenue by Region: 2018 VS 2024 VS 2034
9.3.2 Asia S-Amlodipine Revenue by Region (2018-2034)
9.3.3 Asia S-Amlodipine Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America S-Amlodipine Market Size by Type
10.1.1 Middle East, Africa and Latin America S-Amlodipine Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America S-Amlodipine Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America S-Amlodipine Market Size by Application
10.2.1 Middle East, Africa and Latin America S-Amlodipine Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America S-Amlodipine Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America S-Amlodipine Sales by Country
10.3.1 Middle East, Africa and Latin America S-Amlodipine Revenue by Country: 2018 VS 2024 VS 2034
10.3.2 Middle East, Africa and Latin America S-Amlodipine Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America S-Amlodipine Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Aristo Pharmaceuticals Pvt Ltd
11.1.1 Aristo Pharmaceuticals Pvt Ltd Company Information
11.1.2 Aristo Pharmaceuticals Pvt Ltd Overview
11.1.3 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aristo Pharmaceuticals Pvt Ltd Recent Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Overview
11.2.3 Novartis S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Novartis S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Pfizer S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Lek
11.4.1 Lek Company Information
11.4.2 Lek Overview
11.4.3 Lek S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Lek S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lek Recent Developments
11.5 TEVA
11.5.1 TEVA Company Information
11.5.2 TEVA Overview
11.5.3 TEVA S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 TEVA S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 TEVA Recent Developments
11.6 Macleods Pharmaceuticals
11.6.1 Macleods Pharmaceuticals Company Information
11.6.2 Macleods Pharmaceuticals Overview
11.6.3 Macleods Pharmaceuticals S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Macleods Pharmaceuticals S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Macleods Pharmaceuticals Recent Developments
11.7 Caraco Pharmaceutical
11.7.1 Caraco Pharmaceutical Company Information
11.7.2 Caraco Pharmaceutical Overview
11.7.3 Caraco Pharmaceutical S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Caraco Pharmaceutical S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Caraco Pharmaceutical Recent Developments
11.8 Sanis Health
11.8.1 Sanis Health Company Information
11.8.2 Sanis Health Overview
11.8.3 Sanis Health S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Sanis Health S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanis Health Recent Developments
11.9 Jamp Pharma
11.9.1 Jamp Pharma Company Information
11.9.2 Jamp Pharma Overview
11.9.3 Jamp Pharma S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Jamp Pharma S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Jamp Pharma Recent Developments
11.10 Accel Pharma
11.10.1 Accel Pharma Company Information
11.10.2 Accel Pharma Overview
11.10.3 Accel Pharma S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Accel Pharma S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Accel Pharma Recent Developments
11.11 Jubilant Generics
11.11.1 Jubilant Generics Company Information
11.11.2 Jubilant Generics Overview
11.11.3 Jubilant Generics S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Jubilant Generics S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jubilant Generics Recent Developments
11.12 Angita Pharma
11.12.1 Angita Pharma Company Information
11.12.2 Angita Pharma Overview
11.12.3 Angita Pharma S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Angita Pharma S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Angita Pharma Recent Developments
11.13 Florida DOH Central Pharmacy
11.13.1 Florida DOH Central Pharmacy Company Information
11.13.2 Florida DOH Central Pharmacy Overview
11.13.3 Florida DOH Central Pharmacy S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Florida DOH Central Pharmacy S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Florida DOH Central Pharmacy Recent Developments
11.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
11.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Company Information
11.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Overview
11.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments
11.15 Yangzijiang Pharmaceutical
11.15.1 Yangzijiang Pharmaceutical Company Information
11.15.2 Yangzijiang Pharmaceutical Overview
11.15.3 Yangzijiang Pharmaceutical S-Amlodipine Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Yangzijiang Pharmaceutical S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Yangzijiang Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 S-Amlodipine Industry Chain Analysis
12.2 S-Amlodipine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 S-Amlodipine Production Mode & Process
12.4 S-Amlodipine Sales and Marketing
12.4.1 S-Amlodipine Sales Channels
12.4.2 S-Amlodipine Distributors
12.5 S-Amlodipine Customers
13 Market Dynamics
13.1 S-Amlodipine Industry Trends
13.2 S-Amlodipine Market Drivers
13.3 S-Amlodipine Market Challenges
13.4 S-Amlodipine Market Restraints
14 Key Findings in The Global S-Amlodipine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figure
List of Tables
Table 1. Global S-Amlodipine Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Amlodipine Besylate Tablets
Table 3. Major Manufacturers of Amlodipine Mesylate Tablets
Table 4. Major Manufacturers of Amlodipine Maleate Tablets
Table 5. Global S-Amlodipine Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global S-Amlodipine Revenue Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global S-Amlodipine Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global S-Amlodipine Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global S-Amlodipine Revenue Market Share by Region (2018-2023)
Table 10. Global S-Amlodipine Revenue Market Share by Region (2024-2034)
Table 11. Global S-Amlodipine Sales Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 12. Global S-Amlodipine Sales by Region (2018-2023) & (K Units)
Table 13. Global S-Amlodipine Sales by Region (2024-2034) & (K Units)
Table 14. Global S-Amlodipine Sales Market Share by Region (2018-2023)
Table 15. Global S-Amlodipine Sales Market Share by Region (2024-2034)
Table 16. Global S-Amlodipine Sales by Manufacturers (2018-2023) & (K Units)
Table 17. Global S-Amlodipine Sales Share by Manufacturers (2018-2023)
Table 18. Global S-Amlodipine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global S-Amlodipine Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of S-Amlodipine, Industry Ranking, 2021 VS 2024 VS 2023
Table 21. S-Amlodipine Price by Manufacturers 2018-2023 (US$/Unit)
Table 22. Global S-Amlodipine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global S-Amlodipine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in S-Amlodipine as of 2024)
Table 24. Global Key Manufacturers of S-Amlodipine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of S-Amlodipine, Product Offered and Application
Table 26. Global Key Manufacturers of S-Amlodipine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 29. Global S-Amlodipine Sales by Type (2024-2034) & (K Units)
Table 30. Global S-Amlodipine Sales Share by Type (2018-2023)
Table 31. Global S-Amlodipine Sales Share by Type (2024-2034)
Table 32. Global S-Amlodipine Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global S-Amlodipine Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global S-Amlodipine Revenue Share by Type (2018-2023)
Table 35. Global S-Amlodipine Revenue Share by Type (2024-2034)
Table 36. S-Amlodipine Price by Type (2018-2023) & (US$/Unit)
Table 37. Global S-Amlodipine Price Forecast by Type (2024-2034) & (US$/Unit)
Table 38. Global S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 39. Global S-Amlodipine Sales by Application (2024-2034) & (K Units)
Table 40. Global S-Amlodipine Sales Share by Application (2018-2023)
Table 41. Global S-Amlodipine Sales Share by Application (2024-2034)
Table 42. Global S-Amlodipine Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global S-Amlodipine Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global S-Amlodipine Revenue Share by Application (2018-2023)
Table 45. Global S-Amlodipine Revenue Share by Application (2024-2034)
Table 46. S-Amlodipine Price by Application (2018-2023) & (US$/Unit)
Table 47. Global S-Amlodipine Price Forecast by Application (2024-2034) & (US$/Unit)
Table 48. US & Canada S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 49. US & Canada S-Amlodipine Sales by Type (2024-2034) & (K Units)
Table 50. US & Canada S-Amlodipine Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada S-Amlodipine Revenue by Type (2024-2034) & (US$ Million)
Table 52. US & Canada S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 53. US & Canada S-Amlodipine Sales by Application (2024-2034) & (K Units)
Table 54. US & Canada S-Amlodipine Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada S-Amlodipine Revenue by Application (2024-2034) & (US$ Million)
Table 56. US & Canada S-Amlodipine Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 57. US & Canada S-Amlodipine Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada S-Amlodipine Revenue by Country (2024-2034) & (US$ Million)
Table 59. US & Canada S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 60. US & Canada S-Amlodipine Sales by Country (2024-2034) & (K Units)
Table 61. Europe S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 62. Europe S-Amlodipine Sales by Type (2024-2034) & (K Units)
Table 63. Europe S-Amlodipine Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe S-Amlodipine Revenue by Type (2024-2034) & (US$ Million)
Table 65. Europe S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 66. Europe S-Amlodipine Sales by Application (2024-2034) & (K Units)
Table 67. Europe S-Amlodipine Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe S-Amlodipine Revenue by Application (2024-2034) & (US$ Million)
Table 69. Europe S-Amlodipine Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 70. Europe S-Amlodipine Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe S-Amlodipine Revenue by Country (2024-2034) & (US$ Million)
Table 72. Europe S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 73. Europe S-Amlodipine Sales by Country (2024-2034) & (K Units)
Table 74. China S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 75. China S-Amlodipine Sales by Type (2024-2034) & (K Units)
Table 76. China S-Amlodipine Revenue by Type (2018-2023) & (US$ Million)
Table 77. China S-Amlodipine Revenue by Type (2024-2034) & (US$ Million)
Table 78. China S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 79. China S-Amlodipine Sales by Application (2024-2034) & (K Units)
Table 80. China S-Amlodipine Revenue by Application (2018-2023) & (US$ Million)
Table 81. China S-Amlodipine Revenue by Application (2024-2034) & (US$ Million)
Table 82. Asia S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 83. Asia S-Amlodipine Sales by Type (2024-2034) & (K Units)
Table 84. Asia S-Amlodipine Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia S-Amlodipine Revenue by Type (2024-2034) & (US$ Million)
Table 86. Asia S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 87. Asia S-Amlodipine Sales by Application (2024-2034) & (K Units)
Table 88. Asia S-Amlodipine Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia S-Amlodipine Revenue by Application (2024-2034) & (US$ Million)
Table 90. Asia S-Amlodipine Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 91. Asia S-Amlodipine Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia S-Amlodipine Revenue by Region (2024-2034) & (US$ Million)
Table 93. Asia S-Amlodipine Sales by Region (2018-2023) & (K Units)
Table 94. Asia S-Amlodipine Sales by Region (2024-2034) & (K Units)
Table 95. Middle East, Africa and Latin America S-Amlodipine Sales by Type (2018-2023) & (K Units)
Table 96. Middle East, Africa and Latin America S-Amlodipine Sales by Type (2024-2034) & (K Units)
Table 97. Middle East, Africa and Latin America S-Amlodipine Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America S-Amlodipine Revenue by Type (2024-2034) & (US$ Million)
Table 99. Middle East, Africa and Latin America S-Amlodipine Sales by Application (2018-2023) & (K Units)
Table 100. Middle East, Africa and Latin America S-Amlodipine Sales by Application (2024-2034) & (K Units)
Table 101. Middle East, Africa and Latin America S-Amlodipine Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America S-Amlodipine Revenue by Application (2024-2034) & (US$ Million)
Table 103. Middle East, Africa and Latin America S-Amlodipine Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 104. Middle East, Africa and Latin America S-Amlodipine Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America S-Amlodipine Revenue by Country (2024-2034) & (US$ Million)
Table 106. Middle East, Africa and Latin America S-Amlodipine Sales by Country (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America S-Amlodipine Sales by Country (2024-2034) & (K Units)
Table 108. Aristo Pharmaceuticals Pvt Ltd Company Information
Table 109. Aristo Pharmaceuticals Pvt Ltd Description and Major Businesses
Table 110. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Aristo Pharmaceuticals Pvt Ltd Recent Developments
Table 113. Novartis Company Information
Table 114. Novartis Description and Major Businesses
Table 115. Novartis S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Novartis S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Novartis Recent Developments
Table 118. Pfizer Company Information
Table 119. Pfizer Description and Major Businesses
Table 120. Pfizer S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Pfizer S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Pfizer Recent Developments
Table 123. Lek Company Information
Table 124. Lek Description and Major Businesses
Table 125. Lek S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Lek S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Lek Recent Developments
Table 128. TEVA Company Information
Table 129. TEVA Description and Major Businesses
Table 130. TEVA S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. TEVA S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. TEVA Recent Developments
Table 133. Macleods Pharmaceuticals Company Information
Table 134. Macleods Pharmaceuticals Description and Major Businesses
Table 135. Macleods Pharmaceuticals S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Macleods Pharmaceuticals S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Macleods Pharmaceuticals Recent Developments
Table 138. Caraco Pharmaceutical Company Information
Table 139. Caraco Pharmaceutical Description and Major Businesses
Table 140. Caraco Pharmaceutical S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Caraco Pharmaceutical S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Caraco Pharmaceutical Recent Developments
Table 143. Sanis Health Company Information
Table 144. Sanis Health Description and Major Businesses
Table 145. Sanis Health S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Sanis Health S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Sanis Health Recent Developments
Table 148. Jamp Pharma Company Information
Table 149. Jamp Pharma Description and Major Businesses
Table 150. Jamp Pharma S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Jamp Pharma S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Jamp Pharma Recent Developments
Table 153. Accel Pharma Company Information
Table 154. Accel Pharma Description and Major Businesses
Table 155. Accel Pharma S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Accel Pharma S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Accel Pharma Recent Developments
Table 158. Jubilant Generics Company Information
Table 159. Jubilant Generics Description and Major Businesses
Table 160. Jubilant Generics S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Jubilant Generics S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Jubilant Generics Recent Developments
Table 163. Angita Pharma Company Information
Table 164. Angita Pharma Description and Major Businesses
Table 165. Angita Pharma S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Angita Pharma S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Angita Pharma Recent Developments
Table 168. Florida DOH Central Pharmacy Company Information
Table 169. Florida DOH Central Pharmacy Description and Major Businesses
Table 170. Florida DOH Central Pharmacy S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Florida DOH Central Pharmacy S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Florida DOH Central Pharmacy Recent Developments
Table 173. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Company Information
Table 174. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 175. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments
Table 178. Yangzijiang Pharmaceutical Company Information
Table 179. Yangzijiang Pharmaceutical Description and Major Businesses
Table 180. Yangzijiang Pharmaceutical S-Amlodipine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 181. Yangzijiang Pharmaceutical S-Amlodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Yangzijiang Pharmaceutical Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. S-Amlodipine Distributors List
Table 186. S-Amlodipine Customers List
Table 187. S-Amlodipine Market Trends
Table 188. S-Amlodipine Market Drivers
Table 189. S-Amlodipine Market Challenges
Table 190. S-Amlodipine Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. S-Amlodipine Product Picture
Figure 2. Global S-Amlodipine Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global S-Amlodipine Market Share by Type in 2024 & 2034
Figure 4. Amlodipine Besylate Tablets Product Picture
Figure 5. Amlodipine Mesylate Tablets Product Picture
Figure 6. Amlodipine Maleate Tablets Product Picture
Figure 7. Global S-Amlodipine Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global S-Amlodipine Market Share by Application in 2024 & 2034
Figure 9. Hypertension
Figure 10. Angina pectoris
Figure 11. S-Amlodipine Report Years Considered
Figure 12. Global S-Amlodipine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global S-Amlodipine Revenue 2018-2034 (US$ Million)
Figure 14. Global S-Amlodipine Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 15. Global S-Amlodipine Revenue Market Share by Region (2018-2034)
Figure 16. Global S-Amlodipine Sales 2018-2034 ((K Units)
Figure 17. Global S-Amlodipine Sales Market Share by Region (2018-2034)
Figure 18. US & Canada S-Amlodipine Sales YoY (2018-2034) & (K Units)
Figure 19. US & Canada S-Amlodipine Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe S-Amlodipine Sales YoY (2018-2034) & (K Units)
Figure 21. Europe S-Amlodipine Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China S-Amlodipine Sales YoY (2018-2034) & (K Units)
Figure 23. China S-Amlodipine Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Asia (excluding China) S-Amlodipine Sales YoY (2018-2034) & (K Units)
Figure 25. Asia (excluding China) S-Amlodipine Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America S-Amlodipine Sales YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America S-Amlodipine Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The S-Amlodipine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
Figure 29. The Top 5 and 10 Largest Manufacturers of S-Amlodipine in the World: Market Share by S-Amlodipine Revenue in 2024
Figure 30. Global S-Amlodipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 31. Global S-Amlodipine Sales Market Share by Type (2018-2034)
Figure 32. Global S-Amlodipine Revenue Market Share by Type (2018-2034)
Figure 33. Global S-Amlodipine Sales Market Share by Application (2018-2034)
Figure 34. Global S-Amlodipine Revenue Market Share by Application (2018-2034)
Figure 35. US & Canada S-Amlodipine Sales Market Share by Type (2018-2034)
Figure 36. US & Canada S-Amlodipine Revenue Market Share by Type (2018-2034)
Figure 37. US & Canada S-Amlodipine Sales Market Share by Application (2018-2034)
Figure 38. US & Canada S-Amlodipine Revenue Market Share by Application (2018-2034)
Figure 39. US & Canada S-Amlodipine Revenue Share by Country (2018-2034)
Figure 40. US & Canada S-Amlodipine Sales Share by Country (2018-2034)
Figure 41. U.S. S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 42. Canada S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 43. Europe S-Amlodipine Sales Market Share by Type (2018-2034)
Figure 44. Europe S-Amlodipine Revenue Market Share by Type (2018-2034)
Figure 45. Europe S-Amlodipine Sales Market Share by Application (2018-2034)
Figure 46. Europe S-Amlodipine Revenue Market Share by Application (2018-2034)
Figure 47. Europe S-Amlodipine Revenue Share by Country (2018-2034)
Figure 48. Europe S-Amlodipine Sales Share by Country (2018-2034)
Figure 49. Germany S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 50. France S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 51. U.K. S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 52. Italy S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 53. Russia S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 54. China S-Amlodipine Sales Market Share by Type (2018-2034)
Figure 55. China S-Amlodipine Revenue Market Share by Type (2018-2034)
Figure 56. China S-Amlodipine Sales Market Share by Application (2018-2034)
Figure 57. China S-Amlodipine Revenue Market Share by Application (2018-2034)
Figure 58. Asia S-Amlodipine Sales Market Share by Type (2018-2034)
Figure 59. Asia S-Amlodipine Revenue Market Share by Type (2018-2034)
Figure 60. Asia S-Amlodipine Sales Market Share by Application (2018-2034)
Figure 61. Asia S-Amlodipine Revenue Market Share by Application (2018-2034)
Figure 62. Asia S-Amlodipine Revenue Share by Region (2018-2034)
Figure 63. Asia S-Amlodipine Sales Share by Region (2018-2034)
Figure 64. Japan S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 65. South Korea S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 66. China Taiwan S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 67. Southeast Asia S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 68. India S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 69. Middle East, Africa and Latin America S-Amlodipine Sales Market Share by Type (2018-2034)
Figure 70. Middle East, Africa and Latin America S-Amlodipine Revenue Market Share by Type (2018-2034)
Figure 71. Middle East, Africa and Latin America S-Amlodipine Sales Market Share by Application (2018-2034)
Figure 72. Middle East, Africa and Latin America S-Amlodipine Revenue Market Share by Application (2018-2034)
Figure 73. Middle East, Africa and Latin America S-Amlodipine Revenue Share by Country (2018-2034)
Figure 74. Middle East, Africa and Latin America S-Amlodipine Sales Share by Country (2018-2034)
Figure 75. Brazil S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 76. Mexico S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 77. Turkey S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 78. Israel S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 79. GCC Countries S-Amlodipine Revenue (2018-2034) & (US$ Million)
Figure 80. S-Amlodipine Value Chain
Figure 81. S-Amlodipine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed